These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 23625408)
1. Phosphopeptide microarrays for comparative proteomic profiling of cellular lysates. Gao L; Sun H; Uttamchandani M; Yao SQ Methods Mol Biol; 2013; 1002():233-51. PubMed ID: 23625408 [TBL] [Abstract][Full Text] [Related]
2. Comparative proteomic profiling of mammalian cell lysates using phosphopeptide microarrays. Gao L; Uttamchandani M; Yao SQ Chem Commun (Camb); 2012 Feb; 48(16):2240-2. PubMed ID: 22252530 [TBL] [Abstract][Full Text] [Related]
3. Novel breast cancer biomarkers identified by integrative proteomic and gene expression mapping. Ou K; Yu K; Kesuma D; Hooi M; Huang N; Chen W; Lee SY; Goh XP; Tan LK; Liu J; Soon SY; Bin Abdul Rashid S; Putti TC; Jikuya H; Ichikawa T; Nishimura O; Salto-Tellez M; Tan P J Proteome Res; 2008 Apr; 7(4):1518-28. PubMed ID: 18318472 [TBL] [Abstract][Full Text] [Related]
4. [Proteomics and breast cancer]. Mathelin C; Tomasetto C; Cromer A; Rio MC Gynecol Obstet Fertil; 2006 Dec; 34(12):1161-9. PubMed ID: 17123853 [TBL] [Abstract][Full Text] [Related]
5. Proteomics of breast carcinoma. Somiari RI; Somiari S; Russell S; Shriver CD J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb; 815(1-2):215-25. PubMed ID: 15652811 [TBL] [Abstract][Full Text] [Related]
6. Integrating titania enrichment, iTRAQ labeling, and Orbitrap CID-HCD for global identification and quantitative analysis of phosphopeptides. Wu J; Warren P; Shakey Q; Sousa E; Hill A; Ryan TE; He T Proteomics; 2010 Jun; 10(11):2224-34. PubMed ID: 20340162 [TBL] [Abstract][Full Text] [Related]
7. Proteome profile of the MCF7 cancer cell line: a mass spectrometric evaluation. Sarvaiya HA; Yoon JH; Lazar IM Rapid Commun Mass Spectrom; 2006; 20(20):3039-55. PubMed ID: 16986208 [TBL] [Abstract][Full Text] [Related]
8. Clinical proteomics in breast cancer: a review. Gast MC; Schellens JH; Beijnen JH Breast Cancer Res Treat; 2009 Jul; 116(1):17-29. PubMed ID: 19082706 [TBL] [Abstract][Full Text] [Related]
9. Reverse-phase protein microarrays. Pierobon M; Vanmeter AJ; Moroni N; Galdi F; Petricoin EF Methods Mol Biol; 2012; 823():215-35. PubMed ID: 22081348 [TBL] [Abstract][Full Text] [Related]
10. Profiling protein interaction networks with functional protein microarrays. Mattoon DR; Schweitzer B Methods Mol Biol; 2009; 563():63-74. PubMed ID: 19597780 [TBL] [Abstract][Full Text] [Related]
11. Biomarkers of breast cancer apoptosis induced by chemotherapy and TRAIL. Leong S; McKay MJ; Christopherson RI; Baxter RC J Proteome Res; 2012 Feb; 11(2):1240-50. PubMed ID: 22133146 [TBL] [Abstract][Full Text] [Related]
12. Isotope-labeling and affinity enrichment of phosphopeptides for proteomic analysis using liquid chromatography-tandem mass spectrometry. Kota U; Chien KY; Goshe MB Methods Mol Biol; 2009; 564():303-21. PubMed ID: 19544030 [TBL] [Abstract][Full Text] [Related]
13. The molecular make-up of a tumour: proteomics in cancer research. Kolch W; Mischak H; Pitt AR Clin Sci (Lond); 2005 May; 108(5):369-83. PubMed ID: 15831087 [TBL] [Abstract][Full Text] [Related]
15. Investigation of phosphoprotein signatures of archived prostate cancer tissue specimens via proteomic analysis. Chen L; Fang B; Giorgianni F; Gingrich JR; Beranova-Giorgianni S Electrophoresis; 2011 Aug; 32(15):1984-91. PubMed ID: 21739434 [TBL] [Abstract][Full Text] [Related]
16. Protein microarrays for cancer diagnostics and therapy. Lin JC Med Princ Pract; 2010; 19(4):247-54. PubMed ID: 20516699 [TBL] [Abstract][Full Text] [Related]
17. Identification of pathways associated with invasive behavior by ovarian cancer cells using multidimensional protein identification technology (MudPIT). Sodek KL; Evangelou AI; Ignatchenko A; Agochiya M; Brown TJ; Ringuette MJ; Jurisica I; Kislinger T Mol Biosyst; 2008 Jul; 4(7):762-73. PubMed ID: 18563251 [TBL] [Abstract][Full Text] [Related]